Current dyspnea among long-term survivors of early-stage non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 5, Issue 8, 2010, Pages 1221-1226

  Feinstein, Marc B ^a   Krebs, Paul ^a   Coups, Elliot J ^b   Park, Bernard J ^a   Steingart, Richard M ^a   Burkhalter, Jack ^a   Logue, Amy ^a   Ostroff, Jamie S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Carcinoma; Dyspnea; Non small cell lung; Survivors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE FREE INTERVAL; DYSPNEA; EARLY CANCER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DIFFUSION CAPACITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 77955092576     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181df61c8     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714. (Pubitemid 47357522)
3. Charpidou AG, Gkiozos I, Tsimpoukis S, et al. Therapy-induced toxicity of the lungs: an overview. Anticancer Res 2009;29:631-639.
4. De Ruysscher D, Dehing C, Yu S, et al. Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer. Radiother Oncol 2009;91:353-359.
5. Foroulis CN, Lioulias AG, Papakonstantinou C. Simple laboratory parameters which can determine the clinical state of patients after pneumonectomy for lung cancer. J Thorac Oncol 2009;4:55-61.
6. Sarna L, Cooley ME, Brown JK, et al. Symptom severity 1 to 4 months after thoracotomy for lung cancer. Am J Crit Care 2008;17:455-467; quiz 468.
7. Dales RE, Belanger R, Shamji FM, et al. Quality-of-life following thoracotomy for lung cancer. J Clin Epidemiol 1994;47:1443-1449.
8. Sarna L, Evangelista L, Tashkin D, et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest 2004;125:439-445.
9. Callahan CM, Unverzagt FW, Hui SL, et al. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care 2002;40:771-781.
10. Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751-758.
11. Eakin EG, Sassi-Dambron DE, Ries AL, et al. Reliability and validity of dyspnea measures in patients with obstructive lung disease. Int J Behav Med 1995;2:118-134.
12. Yusen RD, Trulock EP, Pohl MS, et al. Results of lung volume reduction surgery in patients with emphysema. The Washington University Emphysema Surgery Group. Semin Thorac Cardiovasc Surg 1996;8:99-109.
13. Saffran L, Ost DE, Fein AM, et al. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 2000;118: 417-421.
14. Mahler DA, Donohue JF, Barbee RA, et al. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999;115:957-965.
15. Sassi-Dambron DE, Eakin EG, Ries AL, et al. Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies. Chest 1995;107:724-729.
16. Napolis LM, Sette A, Bagatin E, et al. Chronic dyspnea and altered respiratory function in former workers with asbestosis evaluated to determine pension benefits. J Bras Pneumol 2004;30:528-534.
17. Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132:161S-177S. (Pubitemid 47502806)
18. Physical Activity for Everyone: Centers for Disease Control and Prevention, 2009.
19. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985;10:141-146.
20. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 1986;292:344.
21. Ries AL, Kaplan RM, Limberg TM, et al. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122:823-832.
22. Cesario A, Ferri L, Galetta D, et al. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer 2007;57:175-180. (Pubitemid 47049761)
23. Clark MM, Novotny PJ, Patten CA, et al. Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer 2008;61:117-122.
24. Borson S, McDonald GJ, Gayle T, et al. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992;33:190-201.
25. Eiser N, Harte R, Spiros K, et al. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2005;2: 233-241.
26. Doorenbos A, Given B, Given C, et al. Physical functioning: effect of behavioral intervention for symptoms among individuals with cancer. NursRes 2006;55:161-171.